Harry W. Wilcox

General Partner and Chief Operating Officer at Flagship Ventures

Location:
55 Cambridge Parkway Suite 800E, Cambridge, Massachusetts, United States
Company:
Flagship Ventures
HQ Phone:
(617) 868-1888
Wrong Harry Wilcox?

Last Updated 11/18/2017

General Information

Employment History

GenomeWeb LLC

Chief Financial Officer and Senior Vice President of Corporate Development  - EXACT Sciences Corporation

Founding Chief Financial Officer and General Partner  - Highland Capital Partners Inc

Education

BS  - finance , University of Arizona

M.B.A.  - Boston University

Affiliations

Board Member  - BG Medicine Inc

Board Member  - Midori Renewables Inc

Board Member  - Seventh Sense Biosystems Inc

President and Chief Executive Officer  - Cambridge NeuroScience , Inc.

Board Member  - Accuri Cytometers , Inc.

Executive Vice President Andchief of Finance and Corporate Development  - Pyrosequencing AB

Board Member  - Quantum Designs LLC

Board Member  - Power Tech Inc

Board Member  - Selventa

Board Member  - T2 Biosystems, Inc.

Board Member  - Celexion LLC.

Board Member  - Be Power Tech, Inc.

Board Member  - HN Company , Inc.

Board Member  - Tangent Medical Technologies Inc

Board Member  - Black Duck Software Inc

Board Member  - Regional Technology Development Corp

Board Member  - Seahorse Bioscience Inc

Director  - VisEn Medical , Inc.

Board Member  - Non-Employee

Founder  - Chief Financial Officer and General Partner

Web References  

Old hands, young scientists team up to bring products to market - Pilot Communications Group, LLC

Harry Wilcox, a general partner at Flagship, said his firm typically backs biotech, medical device, and renewable energy companies, but was intrigued by the food inventions developed by MIT scientist David Edwards.
Venture capital firms have invested a total of about $25 million in the company, Wilcox said. "There's a real need for food without allergens," he added. "Clean food."

Read More
Board of Directors - BG Medicine Inc.BG Medicine Inc.

Harry W. Wilcox / Chairman
Harry W. Wilcox has served on our Board of Directors since May 2015. Mr. Wilcox has been Chief Operating Officer and General Partner of Flagship Ventures, a venture capital firm, since 2013. From 2006 to 2013, he was Chief Financial Officer and Partner of Flagship Ventures. From 2004 to 2006, he was Chief Financial Officer and Senior Vice President of Corporate Development of EXACT Sciences. Mr. Wilcox received his M.B.A. from Boston University and his B.S. in Finance from the University of Arizona. Mr. Wilcox currently serves as a director of T2 Biosystems, Inc., an in vitro diagnostics company.

Read More
About Us > Management Team

Harry Wilcox
Harry Wilcox , CEO and Chairman, COO Flagship Pioneering As COO and general partner at Flagship Pioneering, Harry is responsible for the operational management of Flagship, serves as a member of Flagship's investment committee, and oversees the firm's operations and LP relations/fundraising. He was a board member of Accuri Cytometers prior to its successful sale to Becton Dickinson and of Seahorse BioScience prior to its successful sale to Agilent Technologies. He also plays a role as board member or advisor to select portfolio companies and is currently a board member of Celexion, Seventh Sense Biosystems, T2 Biosystems (NASDAQ:TTOO), Quantum Designs, Inc (Chairman), Selventa, Inc., MidoriUSA (Acting CEO), HN Company, Inc. (Chairman and acting CEO), BG Medicine, Inc. and Be Power Tech. Harry Wilcox Harry Wilcox , CEO and Chairman, COO Flagship Pioneering As COO and general partner at Flagship Pioneering, Harry is responsible for the operational management of Flagship, serves as a member of Flagship's investment committee, and oversees the firm's operations and LP relations/fundraising. He was a board member of Accuri Cytometers prior to its successful sale to Becton Dickinson and of Seahorse BioScience prior to its successful sale to Agilent Technologies. He also plays a role as board member or advisor to select portfolio companies and is currently a board member of Celexion, Seventh Sense Biosystems, T2 Biosystems (NASDAQ:TTOO), Quantum Designs, Inc (Chairman), Selventa, Inc., MidoriUSA (Acting CEO), HN Company, Inc. (Chairman and acting CEO), BG Medicine, Inc. and Be Power Tech.

Read More

Browse ZoomInfo’s Directories